BioCatalyst

LEE011 — catalyst calendar

1 verified catalyst event(s) referencing LEE011, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-01
in 4mo
ESTIMATED
 READOUT
Ribociclib (LEE011) Rollover Study for Continued Access
Phase 2 · Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies
 NVS NOVARTIS AG LEE011 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.